Expert Review of Anticancer Therapy, Volume 21, Issue 2 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 21, Issue 2 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Applying adjuvant therapy for melanoma into clinical practice
Tharani Krishnan, Alexander M Menzies & Rachel Roberts-Thomson
Pages: 129-133
Published online: 01 Nov 2020
First Page PreviewforApplying adjuvant therapy for melanoma into clinical practice | Full Text | References | PDF (330.5 KB) | EPUB
  • 2249 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Triple-negative breast cancer: promising prognostic biomarkers currently in development
Jasmine Sukumar, Kelly Gast, Dionisia Quiroga, Maryam Lustberg & Nicole Williams
Pages: 135-148
Published online: 24 Feb 2021
AbstractforTriple-negative breast cancer: promising prognostic biomarkers currently in development | Full Text | References | PDF (2.3 MB) | EPUB
  • 19988 Views
  • 57 CrossRef citations
  • 0Altmetric
Open Access
Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?
Valentina Norz & Steffen Rausch
Pages: 149-163
Published online: 16 Nov 2020
AbstractforTreatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making? | Full Text | References | PDF (532.3 KB) | EPUB
  • 298 Views
  • 4 CrossRef citations
  • 0Altmetric
The role of the microbiome in drug resistance in gastrointestinal cancers
Ingrid Garajová, Rita Balsano, Heling Wang, Francesco Leonardi, Elisa Giovannetti, Dongmei Deng & Godefridus J. Peters
Pages: 165-176
Published online: 08 Dec 2020
AbstractforThe role of the microbiome in drug resistance in gastrointestinal cancers | Full Text | References | PDF (1.6 MB) | EPUB
  • 5412 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Proton therapy for thoracic malignancies: a review of oncologic outcomes
Nirav V Patel, Nathan Y Yu, Antony Koroulakis, Tejan Diwanji, Amit Sawant, Terence T Sio & Pranshu Mohindra
Pages: 177-191
Published online: 08 Jan 2021
AbstractforProton therapy for thoracic malignancies: a review of oncologic outcomes | Full Text | References | PDF (7.1 MB) | EPUB
  • 228 Views
  • 3 CrossRef citations
  • 0Altmetric
Curative therapy for rectal cancer
Anas Alawawdeh, Tharani Krishnan, Amitesh Roy, Christos Karapetis, Rohit Joshi, Nimit Singhal, Timothy Price & on behalf of the Adelaide Colorectal Tumour Group
Pages: 193-203
Published online: 08 Jan 2021
AbstractforCurative therapy for rectal cancer | Full Text | References | PDF (485.9 KB) | EPUB
  • 393 Views
  • 6 CrossRef citations
  • 0Altmetric
Current surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review
Michael Y. Guo, Jacob J. Wiseman & Sam M. Wiseman
Pages: 205-220
Published online: 15 Dec 2020
AbstractforCurrent surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review | Full Text | References | PDF (588.9 KB) | EPUB
  • 249 Views
  • 2 CrossRef citations
  • 0Altmetric

Drug profile

Article
Pembrolizumab for advanced cervical cancer: safety and efficacy
Francesca De Felice, Elena Giudice, Giulia Bolomini, Maria Grazia Distefano, Giovanni Scambia, Anna Fagotti & Claudia Marchetti
Pages: 221-228
Published online: 26 Nov 2020
AbstractforPembrolizumab for advanced cervical cancer: safety and efficacy | Full Text | References | PDF (1 MB) | EPUB
  • 867 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Pembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy
Marc T Roth & Satya Das
Pages: 229-238
Published online: 04 Dec 2020
AbstractforPembrolizumab in unresectable or metastatic MSI-high colorectal cancer: safety and efficacy | Full Text | References | PDF (1.4 MB) | EPUB
  • 601 Views
  • 9 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 23 Jul 2024
Bevacizumab-containing treatment for relapsed or refractory Wilms tumor
Sarah Al-Jilaihawi et al.
Review Article | Published online: 23 Jul 2024
UNDERSTANDING the LINK BETWEEN ASPARTAME and CANCER
Morando Soffritti
Report | Published online: 23 Jul 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancer
Peter D. Zang et al.
Review Article | Published online: 22 Jul 2024
View all latest articles